Sachin Katyal
Winnipeg, MB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a Decade.
Journal: Current oncology (Toronto, Ont.)
Published: May 13, 2023
Venetoclax inhibits autophagy in chronic lymphocytic leukemia cells.
Journal: Autophagy reports
Published: February 07, 2023
DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease.
Journal: Blood cancer journal
Published: August 16, 2022
Chromatin architecture at susceptible gene loci in cerebellar Purkinje cells characterizes DNA damage-induced neurodegeneration.
Journal: Science advances
Published: December 15, 2021
RAD51-Mediated DNA Homologous Recombination Is Independent of PTEN Mutational Status.
Journal: Cancers
Published: October 09, 2020
The BH3 only Bcl-2 family member BNIP3 regulates cellular proliferation.
Journal: PloS one
Published: April 20, 2018
A mechanism for semaphorin-induced apoptosis: DNA damage of endothelial and myogenic cells in primary cultures from skeletal muscle.
Journal: Oncotarget
Published: September 28, 2017
Cross-resistance and synergy with bendamustine in chronic lymphocytic leukemia.
Journal: Leukemia research
Published: March 18, 2016
TDP1 promotes assembly of non-homologous end joining protein complexes on DNA.
Journal: DNA repair
Published: May 27, 2014
Last Updated: 09/26/2026